Home Access to CRC Screening and Treatment in Rural Communities Access to CRC Screening and Treatment in Rural Communities Fight Colorectal Cancer is joined by Dr. Linda Overholser from the University of Colorado School of Medicine and Kellie Hoffman, a caregiver and colorectal cancer research advocate, for an engaging webinar that explores access to CRC screening and treatment in rural communities. Download slide deck 1 Download slide deck 2 Meet the Speakers Kellie Hoffman I graduated with a B.A. in Radio and Television Broadcasting from Marshall University in 1994. I received an Associate Degree in Paralegal Studies from Mountwest Community College in 2014. I worked in television news for 13 years. I’ve also worked for the Department of Transportation Legal Division and a few law firms. In 2005 my Mom was diagnosed with stage IV colorectal cancer. She had chemotherapy, radiation, surgery and had a colostomy bag for the rest of her life. Her cancer returned in 2009 in her liver. A month after my husband died I had to go to Duke University by myself for them to remove one third of my mom’s liver. Her cancer returned again in early 2014 and she died in April 2014. For all those years I was her only caregiver. I was an only child and my dad died in 2001 from a fall at his work. So I was all Mom had. My interests are reading, painting, gardening and beekeeping. Probably animals and walking as well. And raising two teenagers!! Dr. Linda Overholser Dr. Linda Overholser is a General Internist at the University of Colorado School of Medicine, and the Medical Director for the TACTIC (Thriving After Cancer Treatment is Complete) Clinic at University of Colorado Health. She is also the University of Colorado Cancer Center representative to the NCCN (National Comprehensive Cancer Network) Cancer Survivorship Guidelines Panel, where she is also leading the Second Primary Cancer subcommittee. Her clinical and research interests are in primary care for individuals with a history of cancer, how to best coordinate that care with Oncology providers and in community engagement for cancer survivorship research.